- Report Summary
- Table of Contents
- Enquiry Before Buying
Report Summary
The global companion diagnostics market is expected to grow significantly from USD 3,153 Million in 2018 to USD 10,656 Million in 2025, at a CAGR of 19% from 2019 to 2025. The market growth is attributed to the rising prevalence of chronic diseases, growing demand for personalized medicine, and growing adoption of companion diagnostics. Moreover, technological advancement in diagnosis and treatment, growing number of genetic testing, and increasing merger and acquisition of companies for companion diagnostics test is further propelling the market growth.
Companion diagnostic is a group of clinical tests, which is used to determine the suitability of drug therapy for the patients. It has become an indispensable part of personalized medicine, and will likely continue to rapidly increase in number and application to disease area. Furthermore, it facilitates the clinicians to identify particular patients, who can gain more benefit from the treatment with a specific drug.
The years used for the assessment are as follows:
Historical year: 2015, 2016, 2017
Base year: 2018
Forecast period: 2019 – 2025
RESEARCH METHODOLOGY
The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
- Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
- Interacting with key opinion leaders of the market and developing data points based on interaction with them
- Study of past trends in the market and their year on year Impact on the market size and share
- Analyzing the collected data points
- Bridging the data points to calculate the total global companion diagnostics market and its various segments
- Anticipating potential risks
- Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global companion diagnostics market
- Finalizing the overall size and share of the global companion diagnostics market
OBJECTIVES:
- To classify the global companion diagnostics into segments and analyze their growth prospects individually.
- To analyze market trends, opportunities, drivers and restraints associated with the companion diagnostics market.
- Profiling key companies operating in the global companion diagnostics market
- To study market response with respect to the mergers and acquisitions in the industry.
Table of Contents
TABLE OF CONTENTS
CHAPTER 1. Market Scope and Methodology
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
CHAPTER 2. Executive Summary
2.1. Global Companion Diagnostics- Market Snapshot
CHAPTER 3. Industry Analysis
3.1. Market Definition
3.2. Market Segmentation
3.3. Key Findings of the Global Companion Diagnostics Market
3.4. Market Opportunities & Trends
3.4.1. Emerging applications in oncology and immunology
3.5. Market Driver Analysis
3.5.1. Technological advancement in diagnosis and treatment
3.5.2. Growing adoption of companion diagnostics
3.5.3. Growing demand for personalized medicine
3.5.4. Rising prevalence of chronic diseases
3.5.5. Growing number of genetic testing
3.5.6. Increasing merger and acquisition of companies for companion diagnostics test
3.6. Market Restraint Analysis
3.6.1. Highly diverse regulatory landscape
CHAPTER 4. Competitive Outlook
4.1. Company Share Analysis
4.2. Value Chain Analysis
4.3. Porters Five Forces Analysis
CHAPTER 5. Global Companion Diagnostics Market Size and Forecast (2015 – 2025)
5.1. Global Companion Diagnostics Market, By Product and Service (USD Million)
5.1.1. Assay Kits and Reagents
5.1.2. Software & Services
5.2. Global Companion Diagnostics Market, By Technology (USD Million)
5.2.1. In Situ Hybridization (ISH)
5.2.2. Polymerase Chain Reaction (PCR)
5.2.3. Next-generation Sequencing
5.2.4. Immunohistochemistry (IHC)
5.2.5. Other
5.3. Global Companion Diagnostics Market, By Application (USD Million)
5.3.1. Infectious Diseases
5.3.2. Oncology
5.3.2.1. Blood Cancer
5.3.2.2. Lung Cancer
5.3.2.3. Ovarian Cancer
5.3.2.4. Breast Cancer
5.3.2.5. Pancreatic Cancer
5.3.2.6. Melanoma Cancer
5.3.2.7. Others
5.3.3. Muscular
5.3.4. Gastrointestinal
5.3.5. Neurological
5.3.6. Others
5.4. Global Companion Diagnostics Market, By End-User (USD Million)
5.4.1. Pharmaceutical and Biopharmaceutical Companies
5.4.2. Clinical Research Organization
5.4.3. Others
CHAPTER 6. Global Companion Diagnostics Market, By Geography (2015 – 2025)
6.1. North America Companion Diagnostics Market
6.1.1. North America Companion Diagnostics Market, By Product and Service (USD Million)
6.1.2. North America Companion Diagnostics Market, By Technology (USD Million)
6.1.3. North America Companion Diagnostics Market, By Application (USD Million)
6.1.4. North America Companion Diagnostics Market, By End-User (USD Million)
6.1.5. North America Companion Diagnostics Market, By Country
6.1.5.1. United States
6.1.5.2. Canada
6.1.5.3. Mexico
6.2. Europe Companion Diagnostics Market
6.2.1. Europe Companion Diagnostics Market, By Product and Service (USD Million)
6.2.2. Europe Companion Diagnostics Market, By Technology (USD Million)
6.2.3. Europe Companion Diagnostics Market, By Application (USD Million)
6.2.4. Europe Companion Diagnostics Market, By End-User (USD Million)
6.2.5. Europe Companion Diagnostics Market, By Country
6.2.5.1. France
6.2.5.2. United Kingdom
6.2.5.3. Spain
6.2.5.4. Russia
6.2.5.5. Germany
6.2.5.6. Italy
6.2.5.7. Rest of Europe
6.3. Asia-Pacific Companion Diagnostics Market
6.3.1. Asia-Pacific Companion Diagnostics Market, By Product and Service (USD Million)
6.3.2. Asia-Pacific Companion Diagnostics Market, By Technology (USD Million)
6.3.3. Asia-Pacific Companion Diagnostics Market, By Application (USD Million)
6.3.4. Asia-Pacific Companion Diagnostics Market, By End-User (USD Million)
6.3.5. Asia-Pacific Companion Diagnostics Market, By Country
6.3.5.1. Singapore
6.3.5.2. China
6.3.5.3. India
6.3.5.4. Japan
6.3.5.5. Rest of Asia-Pacific
6.4. Central & South America Companion Diagnostics Market
6.4.1. Central & South America Companion Diagnostics Market, By Product and Service (USD Million)
6.4.2. Central & South America Companion Diagnostics Market, By Technology (USD Million)
6.4.3. Central & South America Companion Diagnostics Market, By Application (USD Million)
6.4.4. Central & South America Companion Diagnostics Market, By End-User (USD Million)
6.4.5. Central & South America Companion Diagnostics Market, By Country
6.4.5.1. Argentina
6.4.5.2. Brazil
6.4.5.3. Rest of Central & South America
6.5. Middle East and Africa Companion Diagnostics Market
6.5.1. Middle East and Africa Companion Diagnostics Market, By Product and Service (USD Million)
6.5.2. Middle East and Africa Companion Diagnostics Market, By Technology (USD Million)
6.5.3. Middle East and Africa Companion Diagnostics Market, By Application (USD Million)
6.5.4. Middle East and Africa Companion Diagnostics Market, By End-User (USD Million)
6.5.5. Middle East and Africa Companion Diagnostics Market, By Country
6.5.5.1. Saudi Arabia
6.5.5.2. South Africa
6.5.5.3. Rest of Middle East and Africa
CHAPTER 7. Key Players and Strategic Developments
7.1. Almac Group
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. Abnova Corporation
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. Qiagen N.V.
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. bioMérieux SA
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. F. Hoffmann-La Roche AG
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Illumina, Inc.
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Agilent Technologies, Inc
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Hologic Inc.
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
7.9. Myriad Genetics, Inc.
7.9.1. Business Overview
7.9.2. Product and Service Offering
7.9.3. Financial Overview
7.9.4. Strategic Developments
Enquiry Before Buying
Global Companion Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2025
Related Reports
-
Global Coronary Stent Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 8, 2019 -
Global Vaginal Slings Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 3, 2019 -
Global Continuous Glucose Monitoring (CGM) Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 2, 2019 -
Global Knee Reconstruction Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
April 29, 2019
The post Global Companion Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025 appeared first on Energias Market Research.
This post first appeared on Market Research Reports, Market Analysis, Market Survey, please read the originial post: here
